Margaret Koziel

Margaret Koziel

Company: Axcella Therapeutics

Job title: Chief Medical Officer


Harnessing Endogenous Metabolic Modulators to Target Multiple Disease Pathways in NASH 3:00 pm

Monitoring disease progression and therapeutic efficacy with non-invasive biomarkers in clinical studies Reversing NASH through targeting multiple pathways Managing diverse patient populations and investigating clinical data: with and without type 2 diabetes and navigating pediatric studiesRead more

day: Day One

Panel Discussion: Obesity, Diabetes & NASH: What do Payers Need to See? 2:00 pm

Defining payer expectations and considering long term value Assessing higher risk patient populations and preventing comorbidities Harmonizing global patient metricsRead more

day: Day 1 Stream 2 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.